Prevention
RSSArticles
-
Team decreases HT meds by 22.3%
-
HT after JNC-VI: Cut costs with early HT control
-
Lifestyle takes a front seat in JNC-VI
-
FDA withdraws channel blocker
-
When does a supplement become a drug?
-
A new $1,000 contender in the anti-platelet ring
-
Device may forestall restenosis
-
Statins go head to head
-
Small rural hospital produces large QIs
-
Cardiovascular disease: What women don't know can kill them